Latest Content

IMM-1-104 Treatment May Improve Responses in Pancreatic Cancer

January 17th 2025, 10:00pm

By Spencer Feldman

Article

A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic cancer.

Kate, Princess of Wales, Enters ‘Survivorship Care Period’ of Cancer Journey

January 17th 2025, 10:00pm

By Alex Biese

Video

An expert explains the new phase of Princess Kate’s cancer journey as she enters remission.

FDA Approves Datroway for HR+, HER2- Breast Cancer

January 17th 2025, 6:54pm

By Alex Biese

Article

Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.

Carrying the Torch: From Colorectal Cancer Survivor to Advocate

January 17th 2025, 6:00pm

By Joe Bullock

Article

As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their legacy of advocacy.

‘Nanny 911’ Star Deborah Finck Died, Danielle Fishel Completed Radiation and More

January 17th 2025, 4:00pm

By Alex Biese

Article

From the death of a TikTok influencer to an update from a “Boy Meets World” star, here is this week’s news.

Improving Treatment Access to Innovative Therapies in Breast Cancer

January 17th 2025, 2:00pm

By Ryan Scott

Video

Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.

FDA Approves Lumakras with Vectibix in KRAS G12C+ Colorectal Cancer

January 16th 2025, 11:50pm

By Alex Biese

Article

The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received chemotherapy.

FDA Approves Calquence Combo for Mantle Cell Lymphoma

January 16th 2025, 11:17pm

By Alex Biese

Article

The Food and Drug Administration has granted traditional approval to Calquence with bendamustine and Rituxan for some patients with MCL.

An Expert Breaks Down the Meaning of MRD Testing in Cancer Care

January 16th 2025, 10:00pm

By Ryan Scott

Article

Dr. Christopher R. Flowers delved into the meaning of MRD, discussing different ways that it may be tested for in patients with various types of cancer.

Diet Plus Fish Oil May Reduce Ki-67 Biomarkers in Prostate Cancer

January 16th 2025, 8:00pm

By Spencer Feldman

Article

A diet high in omega-3 fatty acids and low in omega-6 fatty acids, taken with fish oil, reduced the Ki-67 index in men with prostate cancer on active surveillance.

Honoring the Memory of Surviving After Cancer

January 16th 2025, 6:00pm

By Mike Verano

Article

Fifteen years after my own cancer journey, I find myself balancing hope and grief as I support a colleague newly diagnosed with cancer.

Surgery May Extend Survival For Patients with GIST and Liver Metastases

January 16th 2025, 4:00pm

By Alex Biese

Article

For patients with gastrointestinal stromal tumors with liver metastases, treatment with surgery and chemotherapy has been found to have survival benefits.

HT-001 Addresses Skin Toxicities in Patients With Cancer

January 16th 2025, 2:00pm

By Ryan Scott

Article

In patients with cancer, HT-001, designed to address skin toxicities, elicited encouraging interim safety and efficacy results in the CLEER-001 trial

The Subcutaneous Approval of Opdivo Makes Waves in Future of Cancer Care

January 15th 2025, 10:00pm

By Ryan Scott

Article

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient access, according to experts.

Polycythemia Vera: Treatment Options

January 15th 2025, 9:37pm

By Julie Huynh-Lu, P.A.

Video

panelist discusses how polycythemia vera (PV) treatment approaches include both therapeutic phlebotomy and medications like hydroxyurea or interferon to control blood counts, with treatment selection based on individual risk factors and symptoms, while patients can actively participate in their care through lifestyle modifications and regular monitoring of blood counts, symptoms and cardiovascular risk factors to achieve both immediate symptom relief and long-term disease control.